Laura Tenbrink

Laura Tenbrink has a diverse work experience in the clinical research field. Laura is currently working as an Associate Director of TMF Operations at Vanguard Clinical, Inc. starting in June 2023. Prior to this, they worked at EQRx as a Senior TMF Manager from December 2021 to May 2023, and as a TMF Manager from September 2020 to December 2021. Before EQRx, they were employed at ExecuPharm as a TMF Study Owner from March 2020 to September 2020. Earlier in their career, they worked at Xcovery as a TMF Manager from May 2018 to March 2020, and at IQVIA in various roles including TMF Quality Project Manager from June 2017 to May 2018, TMF Specialist from January 2016 to June 2017, and Sr. Clinical Trials Associate from January 2014 to January 2016. Additionally, Laura Tenbrink has experience as a Respiratory Therapist at the University of Kansas Medical Center from January 2013 to January 2014.

Laura Tenbrink has a Bachelor of Science (BS) degree in Respiratory Care Therapy/Therapist from the University of Kansas Medical Center, which they completed in 2016. Prior to that, they obtained an Associate of Science (A.S.) degree in Respiratory Care Therapy/Therapist from Johnson County Community College in 2013. In terms of additional certifications, Laura has received the "Good Clinical Practice for Clinical Trials" certificate from Citi in September 2020. Laura is also a Registered Respiratory Therapist, although the specific institution and the year of obtaining this certification were not provided.